Here's How Much $100 Invested In CRISPR Therapeutics 5 Years Ago Would Be Worth Today
Portfolio Pulse from Benzinga Insights
CRISPR Therapeutics (NASDAQ:CRSP) has delivered an average annual return of 15.64% over the past 5 years, outperforming the market by 2.15% annually. A $100 investment in CRSP 5 years ago would be worth $223.41 today. The company's market capitalization stands at $5.00 billion.
January 01, 2024 | 4:31 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
CRISPR Therapeutics has seen a significant return of 15.64% annually over the past 5 years, with a $100 investment growing to $223.41.
The historical performance of CRISPR Therapeutics has been strong, with a 15.64% average annual return over the past 5 years. This outperformance compared to the market is likely to be viewed positively by investors, potentially leading to increased investor confidence and a short-term positive impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100